Cytosorbents Corporation (CTSO) Live Share Price, Invest From India

Cytosorbents Corporation Stock Performance

as on June 18, 2026 at 2:15 pm IST

Day's Low
Day's High
$0.46
Day's Price Range
$0.50
$0.48
4.17%
Downside
4.17%
Upside
52 Week's Low
52 Week's High
$0.37
52-Week Price Range
$1.39
$0.48
23.02%
Downside
189.58%
Upside

Cytosorbents Corporation share price movements today

Previous Close: $0.52
Open: $0.50
Volume: 556.1K
Day's Low - High: $0.46 - $0.50
52 Week Low - High: $0.37 - $1.39

Cytosorbents Corporation Historical Returns

1 Month Return: -0.42 %
3 Month Return: -26.63 %
1 Year Return: -58.88 %
3 Year Return: -86.25 %
5 Year Return: -93.78 %

Cytosorbents Corporation Stock Fundamentals & Key Indicators

Check Cytosorbents Corporation market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$32.6M

EPS (TTM)

-0.185

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-11.9M

Revenue (TTM)

37.2M

Profit Margin

-31.85%

Return On Equity TTM

-141.58%

Cytosorbents Corporation vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cytosorbents Corporation with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Cytosorbents Corporation	BUY	$32.6M	-93.78%	NA	-31.85%	NA
Stryker Corporation	BUY	$119.1B	18.14%	35.99	13.21%	1.1199999999999999%
Edwards Lifesciences Corp	BUY	$51.0B	-13.93%	46.62	17.39%	NA
Medtronic plc	BUY	$104.4B	-36.59%	21.57	13.20%	3.53%
Abbott Laboratories	BUY	$157.8B	-19.79%	25.38	13.90%	2.75%

See all

Stock Returns calculator for Cytosorbents Corporation Stock including INR - Dollar returns

The Cytosorbents Corporation stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Cytosorbents Corporation investment value today

Current value as on today

₹45,217

Returns

-₹54,783

(-54.78%)

Returns from Cytosorbents Corporation Stock

-₹58,621 (-58.62%)

Dollar Impact

₹3,838 (+3.84%)

Analyst Recommendation on Cytosorbents Corporation Stock

Based on 9 analysts

BUY

77.78%

Buy

22.22%

Hold

0.00%

Sell

Based on 9 analysts, 77.78% of analysts recommend a 'BUY' rating for Cytosorbents Corporation. Average target price of $2.88

Cytosorbents Corporation Share Price Target

Get share price movements and forecasts by analysts on Cytosorbents Corporation.

What analysts predicted

83.33%UPSIDE

Target Price

$2.88

Current Price

$0.48

Analyzed by

9 Analysts

Target

$2.88

Cytosorbents Corporation target price $2.88, a slight upside of 83.33% compared to current price of $0.48. According to 9 analysts rating.

Indian Investors' Interest in Cytosorbents Corporation Stock

Search interest for Cytosorbents Corporation Stock has increased by 123% in the last 30 days, reflecting an upward trend in search activity.

Time period: May 19, 2026 to June 18, 2026

Change:123% versus previous 30 day period

Cytosorbents Corporation Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	7	8	8	8	9	8	9	9	9	8
Gross Profit	5	6	6	4	9	6	6	6	6	6
Operating Income	-9	-4	-3	-4	-4	-3	-3	-2	-3	-3
EBITDA	-6	-5	-3	-1	-8	0	3	-2	-4	-3
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-6	-6	-4	-2	-9	-1	1	-3	-5	-5
Income Tax Expense	0	0	0	-	-1	-	-	0	-	-
Net Income	-6	-6	-4	-2	-7	-1	1	-3	-5	-5
Net Profit Margin	-83.48%	-67.73%	-48.56%	-27.10%	-86.16%	-16.94%	20.25%	-33.42%	-59.53%	-57.86%

Cytosorbents Corporation Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	8	13	20	22	39	40	34	31	35	37
Gross Profit	4	7	12	15	28	29	20	21	24	26
Operating Income	-11	-9	-15	-18	-10	-22	-31	-31	-16	-14
EBITDA	-11	-8	-15	-18	-9	-21	-30	-27	-19	-4
Interest Expense	0	0	1	1	1	3	0	0	1	2
Depreciation	-	0	0	0	0	1	1	2	1	1
Income Before Tax	-12	-9	-17	-20	-8	-25	-33	-30	-22	-8
Income Tax Expense	0	0	0	-1	-1	0	-1	0	-1	0
Net Income	-11	-8	-17	-19	-7	-24	-32	-29	-20	-8
Net Profit Margin	-145.49%	-63.23%	-84.98%	-84.63%	-19.86%	-61.23%	-94.59%	-94.09%	-58.21%	-22.12%

Cytosorbents Corporation Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-6	-4	-2	-7	-1	1	-3	-5	-5
Operating Cash Flow	-4	-4	-2	-2	-3	-1	-2	-4	-1
Investing Cash Flow	0	0	0	0	0	0	0	0	0
Financing Cash Flow	0	9	0	0	6	0	-	2	-
Change in Cash	-5	0	-2	-2	3	-1	-2	-1	-1

Cytosorbents Corporation Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-8	-17	-19	-7	-24	-32	-28	-20	-8
Operating Cash Flow	-6	-10	-16	-5	-14	-28	-21	-14	-12
Investing Cash Flow	-1	-1	-1	-1	-4	-6	0	0	0
Financing Cash Flow	20	17	8	66	0	4	14	9	9
Change in Cash	12	5	-10	59	-17	-29	-8	-5	-1

Global Institutional Holdings in Cytosorbents Corporation

Funds	Holdings
Sargent Investment Group, LLC	0.88%
Atlantic Trust Group, LLC	0.27%
Advisor Group Holdings, Inc.	0.21%
Nwf Advisory Services Inc	0.17%
Kestra Advisory Services, LLC	0.11%

See all

Insights on Cytosorbents Corporation

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -5.49M → -5.12M (in $), with an average increase of 7.2% per quarter
POSITIVE IMPACT
Price Rise
In the last 7 days, CTSO stock has moved up by 22.9%
NO EFFECT
Against Peers
In the last 1 year, Edwards Lifesciences Corp has given 17.2% return, outperforming this stock by 76.1%
NO EFFECT
Against Peers
In the last 3 years, Cytosorbents Corporation Common Stock has experienced a drawdown of -86.3%, however Stryker Corporation resisted the overall trend and outperformed by 80.6%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 4 quarters, 9.61M → 8.86M (in $), with an average decrease of 2.7% per quarter

About Cytosorbents Corporation

Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform in the United States, Germany, and internationally. Its flagship product, CytoSorb, is an extracorporeal blood purification cartridge to reduce cytokine storms in common critical illnesses, bilirubin in liver failure, myoglobin in trauma and critical illnesses, and inflammatory mediators and blood thinners in cardiac surgery applications, as well as to remove antithrombotic drugs and inflammatory mediators in cardiothoracic surgery applications. The company also develops DrugSorb-ATR antithrombotic removal system, an investigational device to reduce the severity of perioperative bleeding in high-risk surgery due to blood thinning drugs; ECOS-300CY to reduce cytokines and other inflammatory mediators when used in an ex vivo organ perfusion system; VetResQ, a broad-spectrum blood purification adsorber for the treatment of septic shock, toxic shock syndrome, toxin-mediated diseases, pancreatitis, trauma, liver failure, heat stroke, and lung injury in animals; and PuriFi, an advanced hemoperfusion pump for blood purification therapies. In addition, it develops HemoDefend-BGA, a blood purification technology platform to reduce anti-A and anti-B antibodies in plasma and whole blood. The company was formerly known as MedaSorb Technologies Corporation and changed its name to Cytosorbents Corporation in May 2010. Cytosorbents Corporation was founded in 1997 and is headquartered in Princeton, New Jersey.

Organisation	Cytosorbents Corporation
Headquarters	305 College Road East, Princeton, NJ, United States, 08540
Industry	Medical Devices
CEO	Dr. Phillip P. Chan M.D., Ph.D.
E-voting on shares	Click here to vote

Key Management of Cytosorbents Corporation

Name	Title
Jodi Hoover	Executive
Dr. Robert H. Bartlett M.D.	Co-Chairman of Cardiac Surgery Advisory Board & Consultant
Dr. Phillip P. Chan M.D., Ph.D.	CEO & Director
Mr. Vincent J. Capponi M.S.	President & COO
Dr. Christian Steiner M.D.	Executive Vice President of Sales & Marketing
Mr. Christopher Cramer M.B.A., M.S.	Senior Vice President of Business Development
Ms. Kathleen P. Bloch CPA, M.B.A.	Advisor
Mr. Peter J. Mariani CPA	Chief Financial Officer
Dr. Efthymios N. Deliargyris FACC, FESC, FSCAI, M.D.	Chief Medical Officer

FAQs

What is Cytosorbents Corporation share price today?

Cytosorbents Corporation share price today is $0.48 as on June 18, 2026 at 8:45 am IST at the close of the market. Cytosorbents Corporation share today touched a day high of $0.5 and a low of $0.46.

What is the 52 week high and 52 week low for Cytosorbents Corporation share?

Cytosorbents Corporation share touched a 52 week high of $1.39 on June 24, 2025 and a 52 week low of $0.37 on June 11, 2026. Cytosorbents Corporation stock price today i.e. June 18, 2026 at 8:45 am IST is closed at $0.48,which is 65.47% down from its 52 week high and 29.91% up from its 52 week low.

What is Cytosorbents Corporation's market capitalisation today?

Cytosorbents Corporation market capitalisation is $0.00T as on June 18, 2026 at 8:45 am IST.

How to invest in Cytosorbents Corporation Stock (CTSO) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Cytosorbents Corporation on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cytosorbents Corporation Shares that will get you 3.1250 shares as per Cytosorbents Corporation share price of $0.48 per share as on June 18, 2026 at 8:45 am IST.

What is the minimum amount required to buy Cytosorbents Corporation Stock (CTSO) from India?

Indian investors can start investing in Cytosorbents Corporation (CTSO) shares with as little as ₹94.323 or $1 (as of June 18, 2026 at 4:06 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹943.23 in Cytosorbents Corporation stock (as per the Rupee-Dollar exchange rate as on June 18, 2026 at 4:06 pm IST). Based on Cytosorbents Corporation share’s latest price of $0.48 as on June 18, 2026 at 8:45 am IST, you will get 20.8333 shares of Cytosorbents Corporation. Learn more about fractional shares .

What are the returns that Cytosorbents Corporation has given to Indian investors in the last 5 years?

Cytosorbents Corporation stock has given -93.78% share price returns and 27.67% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?